| Patents for C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069) |
|---|
| 01/02/2007 | CA2177602C N-substituted azabicycloalkane derivatives, their preparation and use |
| 12/28/2006 | WO2006107273A8 Compounds having progestogenic activity and their use |
| 12/27/2006 | EP1735317A1 Annelated quinoline derivatives as pesticide |
| 12/14/2006 | WO2006105291A3 Heterocyclical chromophore architectures with novel electronic acceptor systems |
| 12/06/2006 | CN1872859A Compound of heterocyclic pyridine class |
| 12/06/2006 | CN1288157C Dioxadiene pyridine compounds for treating impaired fundic relaxation, method of preparation and use thereof |
| 12/05/2006 | US7144913 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists |
| 11/28/2006 | CA2305370C Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function |
| 11/23/2006 | WO2005054234A8 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy |
| 11/09/2006 | WO2006117800A2 Novel 3, 4-propylenedioxythiophene derivatives with pendant functional groups |
| 11/02/2006 | WO2006116764A1 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity |
| 10/26/2006 | WO2006036941A3 Specific kinase inhibitors |
| 10/25/2006 | CN1852712A Dual NK1/NK3 antagonists for treating schizophrenia |
| 10/24/2006 | CA2167584C Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity |
| 10/19/2006 | WO2006081178A3 Antibacterial agents |
| 10/19/2006 | US20060234987 Neuroprotective benzo 1 3 oxathiol 2 ones |
| 10/18/2006 | EP1711505A2 Process for the preparation of thiazolopyrimidines |
| 10/05/2006 | WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators |
| 10/05/2006 | CA2585333A1 Heterocyclical chromophore architectures with novel electronic acceptor systems |
| 10/03/2006 | US7115743 For treatment of leukemia, carcinomas, adenocarcinomas, and melanoma; assaying metabolism via cytochromes |
| 09/27/2006 | EP1395590B1 Dihydropyrrolo¬1,2-a|indole and tetrahydropyrido¬1,2-a|indole derivatives as prostaglandin d2 receptor antagonists |
| 09/20/2006 | EP1073648B1 12,13-modified epothilone derivatives |
| 09/06/2006 | EP1487836B1 Ethane-1,2-diamino-bis (2r)-2-bromo-3-phenylpropanoate|, method for production and use thereof |
| 08/24/2006 | WO2006020561A3 Antibacterial agents |
| 08/23/2006 | EP1693373A1 Enantiomerically pure beta-D-(-)-dioxolane-nucleosides |
| 08/17/2006 | WO2006076646A3 Heteroaryl substituted quinolin-4-ylamine analogues |
| 08/09/2006 | EP1688418A2 Chemokine receptor antagonists and methods of use thereof |
| 08/03/2006 | WO2006081264A1 Antibacterial agents |
| 07/27/2006 | WO2006050128A3 Heterocyclical chromophore architectures |
| 07/25/2006 | US7081453 Compounds for treating impaired fundic relaxation |
| 07/20/2006 | CA2593482A1 Heteroaryl substituted quinolin-4-ylamine analogues |
| 07/18/2006 | US7078409 Fused quinazoline derivatives useful as tyrosine kinase inhibitors |
| 07/13/2006 | WO2006017468A3 Antibacterial agents |
| 07/13/2006 | WO2004096139A3 Aza spiro alkane derivatives as inhibitors of metalloproteases |
| 07/11/2006 | US7074926 dissolving gases of triethylenediamine in solvents selected form acyclic alcohols-2+ or ethers of these alcohols, then treating with adsorbers such as activated carbon or ion exchangers; purification; storage stability |
| 06/29/2006 | US20060142318 eating disorders of disturbed fundus such as dyspepsia, early satiety, bloating, anorexia; fundic relaxation; 1-[1-[(2,3-dihydro[1,4]dioxino[2,3-b]pyridin-3-yl)methyl]-4-piperidinyl]-2-imidazolidinone; improved pharmacokinetics, less vasoconstriction, side effect reduction, sustain release |
| 06/22/2006 | WO2006036883A3 Imidazo{4,5-b}pyrazinone inhibitors of protein kinases |
| 06/22/2006 | US20060135529 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof |
| 06/08/2006 | US20060122241 Novel macrocycles for the treatment of cancer diseases |
| 06/07/2006 | EP1664038A2 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved i in vivo /i efficacy |
| 06/07/2006 | CN1781921A Compounds for treating impaired fundic relaxation |
| 05/24/2006 | CN1777604A Lyotropic liquid crystal systems based on perylenetetracarboxylic acid dibenzimidazole sulfoderivatives |
| 05/11/2006 | WO2006050435A1 Heterocyclical chromophore architectures |
| 05/11/2006 | CA2584869A1 Heterocyclical chromophore architectures |
| 05/11/2006 | CA2584792A1 Heterocyclical chromophore architectures |
| 05/10/2006 | CN1771037A Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof |
| 05/10/2006 | CN1255411C Benzoxathiepino [3,4-b] pyridine derivatives, process for their preparation and their use as medicaments |
| 04/12/2006 | EP1643998A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 04/06/2006 | CA2581375A1 Specific kinase inhibitors |
| 03/29/2006 | CN1753899A Spirotetrathiocarbamates and spirooxothiocarbamates |
| 03/21/2006 | US7015326 Pyridomorphinans, thienomorphinans and use thereof |
| 03/15/2006 | EP1448566B1 Chemokine receptor antagonists and methods of use thereof |
| 03/08/2006 | EP0736029B1 Anticonvulsant pseudofructopyranose sulfamates |
| 03/07/2006 | US7009047 Reacting ethylenediamine with 2-bromo-3-phenylpropyionic acid; salt formation; angiotensin converting enzyme inhibitor |
| 02/23/2006 | US20060041123 Antibacterial agents |
| 02/14/2006 | US6998485 3a,8a-Bis-azidomethyl-3a,4,8a,9-tetrahydro-3H,8H-bis[1,2,3]triazolo[1,5-a;1'',5''-d]pyrazine; provides low molecular weight energetic compounds with multiple energetic groups |
| 02/09/2006 | WO2006013914A1 Preparation for administration to mouth mucosa |
| 02/08/2006 | EP1622569A2 Aza spiro alkane derivatives as inhibitors of metallproteases |
| 02/01/2006 | EP1619948A1 Sustituted imidazolopyrazine and triazolopyrazine derivatives: gabaa receptor ligands |
| 01/12/2006 | WO2006003329A1 Collection of traceable compounds and uses thereof |
| 01/12/2006 | CA2569545A1 Collection of traceable compounds and uses thereof |
| 01/05/2006 | US20060004065 5,5,7,9,13-%-Pentamethyl-16-[1-methyl-2-(2-methyl)-1,3-thiazol-4-yl)-ethenyl]-6,6-dioxo-1-ox-a-6 lambda 6-thia-cyclohexadeca-10,13-dien-2-one; epothilones and derivatives; improved properties; anticarcinogenic, -tumor agents |
| 01/05/2006 | US20060003997 Substituted benzo[e] [1,4] oxazino [3,2-g] isoindole compounds |
| 01/05/2006 | DE102004029774A1 New 3,4-alkylenedioxy-2,5-dialkoxy-tetrahydrofuran and/or 3,4-arylendioxy-2,5-dialkoxy-tetrahydrofuran compounds useful for preparing e.g. 3,4-alkylenedioxythiophene and/or 3,4-arylenedioxythiophene and 3,4-alkylenedioxyselenophene |
| 12/08/2005 | WO2004096139A8 Aza spiro alkane derivatives as inhibitors of metalloproteases |
| 12/07/2005 | EP1296987B1 Compounds for treating impaired fundic relaxation |
| 12/07/2005 | CN1705669A New benzo-oxazino-isoindole derivatives, useful for treating cancers, are inhibitors of the cell cycle |
| 12/01/2005 | WO2005113561A1 Cyclicsulfonate pyrrole indolinones as kinase inhibitors |
| 11/30/2005 | EP1600448A2 Enantiomerically pure beta-D-(-)-Dioxolane-Nucleosides |
| 11/24/2005 | US20050261326 Metabolites of ecteinascidin 743 |
| 11/09/2005 | EP1204669B1 Tricyclic monosaccharide derivatives useful in treating acute ischemia-induced neurodegeneration |
| 11/03/2005 | DE102004017435A1 Annellierte Chinolinderivate Fused quinoline derivatives |
| 11/02/2005 | EP1589970A2 Pharmaceutical compositions comprising thieno [2,3-c]pyridine deritives and use thereof |
| 11/02/2005 | EP1080095B1 Modulators of protein tyrosine phosphatases (ptpases) |
| 10/26/2005 | EP1589017A2 12,13-modified epothilone derivatives |
| 10/26/2005 | EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators |
| 10/20/2005 | WO2005097802A1 Annelated quinoline derivatives as pesticide |
| 10/19/2005 | CN1683299A Metabolites of ecteinascidin 743 |
| 10/12/2005 | CN1680324A Dihydropyridine soft drugs, and related compositions and methods |
| 10/12/2005 | CN1679612A Enantiomerically pure beta-d-dioxolane nucleosides with selective anti-hepatitus b virus activity |
| 10/05/2005 | EP1581561A2 Spirotetrathiocarbamates and spirooxothiocarbamates |
| 09/29/2005 | WO2005054234A3 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy |
| 09/28/2005 | EP1578743A2 Antibacterial agents |
| 09/22/2005 | US20050209214 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/07/2005 | CN1665821A 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 08/31/2005 | EP1567524A1 Thia-epothilone derivatives for the treatment of cancer |
| 08/25/2005 | WO2005056563A3 Process for the preparation of thiazolopyrimidines |
| 08/17/2005 | EP1200446B1 OXATHIEPINO 6,5- i b /i ]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS |
| 07/27/2005 | EP1556387A1 Substituted benzol e] 1,4] oxazino 3,2-g] isoindole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 07/27/2005 | EP1287004B1 Synthetic process for the manufacture of an ecteinascidin compound |
| 07/07/2005 | US20050148577 2-methyl-1,8-dioxa-dibenzo[e,h]azulene; potentiation; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics |
| 06/30/2005 | US20050143421 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy |
| 06/23/2005 | WO2005056563A2 Process for the preparation of thiazolopyrimidines |
| 06/23/2005 | WO2005056549A1 Water-soluble etoposide analogs and methods of use thereof |
| 06/23/2005 | CA2546719A1 Process for the preparation of thiazolopyrimidines |
| 06/16/2005 | WO2005054234A2 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy |
| 04/28/2005 | US20050090533 Treating schizophrenia by administering an N-(2-aminopyridin-5-yl)amino-phenylisobutyramide, e.g., N-[6-(2-acetylamino-ethylamino)-4-(2-chloro-phenyl)-pyridin-3-yl]-2-(3,5-bis-trifluoromethyl-phenyl)-N-methyl-isobutyramide |
| 04/14/2005 | WO2005007099A3 Pkb inhibitors as anti-tumor agents |
| 04/14/2005 | US20050080047 Chiral diphosphorus compounds and their transition metal complexes |
| 04/13/2005 | EP1521752A1 Novel macrocycles for the treatment of cancer |